""Although much of our research and clinical data has been published domestically, most of it is inaccessible to foreign researchers," said Peng.
As a result, the significant scientific breakthrough has been greeted with indifference or suspicion by many foreign researchers, according to a recent article in the UK-based journal Nature Reviews Drug Discovery."
"Various attempts have been made to promote Chinese research, such as publishing English versions of the Chinese journals, establishing international reviewers' boards, distributing the Chinese journals internationally.
The most recent move towards promotion took place late last month. Under a package deal, China's 34 leading English science journals were collected into ScienceDirect, an online academic database operated by the Amsterdam-based publishing giant Elsevier."
“Bioinformatics will be at the core of biology in the 21st century. In fields ranging from structural biology to genomics to biomedical imaging, ready access to data and analytical tools are fundamentally changing the way investigators in the life sciences conduct research and approach problems. Complex, computationally intensive biological problems are now being addressed and promise to significantly advance our understanding of biology and medicine. No biological discipline will be unaffected by these technological breakthroughs.”BIOINFORMATICS IN THE 21st CENTURY
the panda's thumb
bioinformatics.org / nodalpoint / flags and lollipops / on genetics / a bioinformatics blog / andrew dalke / the struggling grad student / in the pipeline / gene expression / free association / pharyngula / the personal genome / genetics and public health blog / the medical informatics weblog / linuxmednews / nanodot / complexity digest /
nsu / nyt science / bbc scitech / newshub / biology news net /
informatics review / stanford / bmj info in practice / bmj info in practice /
look snazzy and support the site at the same time by buying some snowdeal schwag !
valid xhtml 1.0?
This site designed by
Eric C. Snowdeal III .